
    
      Cycle 1 : Capecitabine 1,250 mg/m2 orally Per os (PO) once a day (BID) for 7 consecutive days
      (D1 - D7) will be administered by subject (with Ideal Body Weight being used to determine
      BSA) for dosage. Day 8-No drug administered.

      Capecitabine 1,250 mg/m2 PO BID for 7 more consecutive days (D9 - D15) will be administered
      by subject (with Actual Body Weight being used to determine BSA) for dosage. There will be 6
      consecutive days that no drug will be administered by subject (Days 16-21).

      Cycle 2 and beyond: Capecitabine 1,250 mg/m2 PO BID for 14 consecutive days (D1 - D14) will
      be administered by subject (with Actual Body Weight being used to determine BSA) for dosage.
      Days 15-21-No drug administered.
    
  